Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States
June 11, 2021
Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States Mont-Saint-Guibert, Belgium – June 10, 2021, 11:30pm CET / 5:30pm ET – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced […]